Last updated on February 2019

Open-Label Randomised Multi-Drug Biomarker-Directed Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer


Contact Investigators or Research Sites near you

Start Over

AstraZeneca Clinical Study Information Center

Research Site
Baltimore, MD United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Kansas City, MO United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
New York, NY United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Cincinnati, OH United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Cleveland, OH United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Nashville, TN United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Milwaukee, WI United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Marseille Cedex 9, France
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Saint Herblain Cedex, France
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Los Angeles, CA United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
New Haven, CT United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Detroit, MI United States
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Fort Myers, FL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.